BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fazeli B, Ligi D, Keramat S, Maniscalco R, Sharebiani H, Mannello F. Recent Updates and Advances in Winiwarter-Buerger Disease (Thromboangiitis Obliterans): Biomolecular Mechanisms, Diagnostics and Clinical Consequences. Diagnostics (Basel) 2021;11:1736. [PMID: 34679434 DOI: 10.3390/diagnostics11101736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zou C, Liu L, Huang C, Hu S. Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways. Front Pharmacol 2022;13:1018438. [DOI: 10.3389/fphar.2022.1018438] [Reference Citation Analysis]
2 Karena ZV, Mehta AD, Rao R, Gowda N, Gadhia VA. An Unusual Case of Buerger’s Disease in a Pregnant Female. Cureus 2022. [DOI: 10.7759/cureus.28382] [Reference Citation Analysis]
3 Chu Y, Wang M, Wang X, Zhang X, Liu L, Shi Y, Zuo L, Du S, Kang J, Li B, Cheng W, Sun Z, Zhang X. Identifying quality markers of Mailuoshutong pill against thromboangiitis obliterans based on chinmedomics strategy. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Elbadawi A, Sedhom R, Megaly M, Eid M, Omran A, Elgendy IY. Estimate and Temporal Trends of Buerger Disease Hospitalizations in the United States. Am J Cardiol 2022;169:158-60. [PMID: 35168750 DOI: 10.1016/j.amjcard.2022.01.014] [Reference Citation Analysis]
5 Fazeli B, Masoudian M. SMOKING AND BUERGER’S DISEASE: FROM HYPOTHESES TO EVIDENCE SYNTHESIS. CAJMHE 2022;3:27-37. [DOI: 10.47316/cajmhe.2022.3.1.03] [Reference Citation Analysis]
6 Keramat S, Karahan O, Patel M, Fazeli B. Acute phase reactant proteins in Buerger's disease: Is it a systemic disease? Vascular 2022;:17085381211069715. [PMID: 35050803 DOI: 10.1177/17085381211069715] [Reference Citation Analysis]